Acrivastine
Names
[ CAS No. ]:
87848-99-5
[ Name ]:
Acrivastine
[Synonym ]:
2-Propenoic acid, 3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl]-, (2E)-
Semprex
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid
(E)-6-[(E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl]-2-pyridineacrylic Acid
Acrivastine
BW 270C
Acrivastinum
BW A825C
Acrivastina
(E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid
MFCD00869830
Acrivastin
Duact
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid
2-propenoic acid, 3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-, (2E)-
BW 825C
Biological Activity
[Description]:
[Related Catalog]:
[In Vivo]
[References]
[Related Small Molecules]
Chemical & Physical Properties
[ Density]:
1.2±0.1 g/cm3
[ Boiling Point ]:
555.1±50.0 °C at 760 mmHg
[ Melting Point ]:
55.5-59.5 °C(lit.)
[ Molecular Formula ]:
C22H24N2O2
[ Molecular Weight ]:
348.438
[ Flash Point ]:
289.5±30.1 °C
[ Exact Mass ]:
348.183777
[ PSA ]:
53.43000
[ LogP ]:
4.55
[ Vapour Pressure ]:
0.0±1.6 mmHg at 25°C
[ Index of Refraction ]:
1.627
[ Storage condition ]:
2-8°C
MSDS
Safety Information
[ Hazard Codes ]:
Xn,Xi
[ Risk Phrases ]:
R22:Harmful if swallowed. R43:May cause sensitization by skin contact.
[ Safety Phrases ]:
S37/39
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ RTECS ]:
UD3474000
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Articles
PLoS ONE 6 , e23852, (2011)
We describe a hitherto unknown feature for 27 small drug-like molecules, namely functional inhibition of acid sphingomyelinase (ASM). These entities named FIASMAs (Functional Inhibitors of Acid Sphing...
Simultaneous analysis of the H1-antihistamine acrivastine and the decongestant pseudoephedrine hydrochloride by high-performance liquid chromatography.J. Pharm. Biomed. Anal. 37(4) , 663-7, (2005)
High-performance liquid chromatography (HPLC) was used for the simultaneous quantification of the H(1)-antihistamine acrivastine and the decongestant pseudoephedrine hydrochloride. Both compounds were...
Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge.Ann. Allergy Asthma Immunol. 84(4) , 451-9, (2000)
Medications containing a combination antihistamine-decongestant are commonly used for allergic rhinitis yet onset-of-action comparisons for symptom relief after a single dose have not been performed.T...